A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab.
Phase of Trial: Phase II
Latest Information Update: 26 May 2015
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 31 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jul 2013 Planned end date changed from 1 Nov 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 12 Jun 2012 Planned end date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.